PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 91 filers reported holding PASSAGE BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $242 | -30.1% | 367,696 | 0.0% | 0.01% | -14.3% |
| Q2 2023 | $346 | -1.7% | 367,696 | 0.0% | 0.01% | -12.5% |
| Q1 2023 | $352 | -30.6% | 367,696 | 0.0% | 0.01% | -42.9% |
| Q4 2022 | $507 | -99.9% | 367,696 | 0.0% | 0.01% | +16.7% |
| Q3 2022 | $460,000 | -36.8% | 367,696 | +19.2% | 0.01% | -45.5% |
| Q2 2022 | $728,000 | -41.3% | 308,445 | -22.9% | 0.02% | -24.1% |
| Q1 2022 | $1,240,000 | -48.8% | 400,000 | +5.0% | 0.03% | -47.3% |
| Q4 2021 | $2,420,000 | -27.7% | 381,034 | +13.4% | 0.06% | -23.6% |
| Q3 2021 | $3,347,000 | -25.6% | 336,034 | -1.1% | 0.07% | -27.3% |
| Q2 2021 | $4,498,000 | -2.9% | 339,701 | +28.2% | 0.10% | -2.9% |
| Q1 2021 | $4,631,000 | -39.7% | 264,911 | -11.9% | 0.10% | -31.1% |
| Q4 2020 | $7,685,000 | +284.8% | 300,554 | +97.3% | 0.15% | +179.2% |
| Q3 2020 | $1,997,000 | -49.5% | 152,325 | +5.3% | 0.05% | -53.1% |
| Q2 2020 | $3,952,000 | +39.5% | 144,592 | -19.6% | 0.11% | +2.7% |
| Q1 2020 | $2,832,000 | – | 179,796 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,648,629 | 2.12% |
| Versant Venture Management, LLC | 4,959,769 | $3,263,528 | 1.74% |
| BML Capital Management, LLC | 2,058,767 | $1,354,669 | 1.24% |
| Acuitas Investments, LLC | 418,161 | $275,150 | 0.16% |
| Orbimed Advisors | 10,124,576 | $6,661,971 | 0.14% |
| Lynx1 Capital Management LP | 190,124 | $125,102 | 0.08% |
| Frazier Life Sciences Management, L.P. | 1,758,219 | $1,156,908 | 0.08% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $263,200 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $56,621 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 506,600 | $333,343 | 0.01% |